Osteosarcoma (Osteogenic sarcoma)

Orphanet Journal of Rare Diseases

Volumn 2, Issue 1, 2007, Pages

  Picci, Piero ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; BONE TUMOR; CANCER STAGING; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INCIDENCE; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; OSTEOSARCOMA; PROGNOSIS; REVIEW; SEX RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BONE NEOPLASMS; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, BONE TISSUE; OSTEOSARCOMA; PROGNOSIS; SEX DISTRIBUTION;

EID: 34247887505     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-2-6     Document Type: Review

References (20)

1. Schajowicz F, Sissons HA, Sobin LH: The World Health Organization's histologic classification of bone tumors. A commentary on the second edition. Cancer 1995, 75(5): 1208-1214.
2. Wolf RE, Enneking WF: The staging and surgery of musculoskeletal neoplasms. Orthop Clin North Am 1996, 27(3):473-481.
3. Campanacci M: Bone and Soft Tissue Tumors: Clinical Features, Imaging, Pathology and Treatment 2nd edition. Wien, Austria: Springer-Verlag; 1999:464-491.
4. Finkel MP, Reilly CA Jr, Biskis BO: Pathogenesis of radiation and virus-induced bone tumors. Recent Results Cancer Res 1976:92-103.
5. Swaney JJ: Familial osteogenic sarcoma. Clin Orthop Relat Res 1973:64-68.
6. Huvos AG: Bone Tumors: Diagnosis. Treatment and Prognosis 2nd edition. Philadelphia, W.B. Saunders. Co; 1991.
7. McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen AL, Yan YX, Russo C, Sato J, Barbier N, Miser J: Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 1994, 12(5):925-930.
8. Mirra JM: Bone Tumors: Clinical, Radiologic and Pathologic Correlations Philadelphia, Lea & Febiger; 1989:248-316.
9. Abramson DH, Ellsworth RM, Zimmerman LE: Nonocular cancer in retinoblastoma survivors. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1976, 81(3 Pt 1):454-457.
10. Grimer RJ, Taminiau AM, Cannon SR: Surgical Subcommitte on behalf of the European Osteosarcoma Intergroup. Surgical outcomes in osteosarcoma. J Bone Joint Surg Br 2002, 84(3):395-400.
11. Bacci G, Ferrari S, Lari S, Mercuri M, Donati D, Longhi A, Forni C, Bertoni F, Versari M, Pignotti E: Osteosarcoma of thelimb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br 2002, 84(1):88-92.
12. Weeden S, Grimer RJ, Cannon SR, Taminiau AH, Uscinska BM: European Osteosarcoma Intergroup. The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer 2001, 37(1):39-46.
13. Picci P, Vanel D, Briccoli A, Talle K, Haakenaasen U, Malaguti C, Monti C, Ferrari C, Bacci G, Saeter G, Alvegard TA: Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001, 12(11): 1601-1604.
14. Bacci G, Briccoli A, Rocca M, Ferrari S, Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, Manfrini M, Galletti S: Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol 2003, 14(7):1126-1134.
15. Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jurgens H, Gadner H, Bielack SS: Cooperative German-Austrian-Swiss Osteosarcoma Study Group. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003, 21(10):2011-2018.
16. Bacci G, Ferrari S, Bertoni F, Ruggieri P, Picci P, Longhi A, Casadei R, Fabbri N, Forni C, Versari M, Campanacci M: Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol 2000, 18(24):4016- 4027.
17. Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, Korholz D, Graf N, Heise U, Jurgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K: Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998, 9(8):893-899.
18. Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES, Kisker CT, Miser JS: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 1997, 15(1):76-84.
19. Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V, Rosen G: Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992, 10(1):5-15.
20. Bacci G, Longhi A, Ferrari S, Lari S, Manfrini M, Donati D, Forni C, Versari M: Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute. Oncol Rep 2002, 9(1):171-175.